In vitro and in vivo evaluation of indomethacin nanoemulsion as a transdermal delivery system

References

• Ammar HO, Salama HA, Ghorab M, Mahmoud AA. (2009). Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmasciTech 10:808–19
   PubMed Web of Science ®Google Scholar
• Baboota S, Shakeel F, Ahuja A, et al. (2007). Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of Celecoxib. Acta Pharm 57:315–32
   PubMedGoogle Scholar
• Badawi AA, El-Laithy HM, El Qidra RK, et al. (2008). Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res 31:1040–9
   PubMed Web of Science ®Google Scholar
• Chauhan AS, Sridevi S, Chalasani KB. (2003). Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release 90:335–43
   PubMed Web of Science ®Google Scholar
• El Maghraby GM. (2010). Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: Effect of phase transition. Colloids Surfaces B Biointerfaces 75:595–600
   PubMed Web of Science ®Google Scholar
• Esposito E, Cortesi R, Drechsler M, et al. (2005). Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 22:2163–73
   PubMed Web of Science ®Google Scholar
• Fang J, Sung KC, Lin H, Fang C. (1999). Transdermal iontophoretic delivery of diclophenac sodium from various polymer formulations: in vitro and in vivo studies. Int J Pharm 178:83–92
   PubMed Web of Science ®Google Scholar
• Goosen C, Plessis JD, Müller DG, Janse van Rensburg LF. (1998). Correlation between physicochemical characteristics, pharmacokinetic properties and transdermal absorption of NSAID’s. Int J Pharm 163:203–9
   Web of Science ®Google Scholar
• Gradzielski M, Langevin D, Parago B. (1996). Experimental investigation of the structure of nonionic microemulsions and their relation to the bending elasticity of the amphiphilic film. Prog Colloid Polym Sci 100:162–9
   Google Scholar
• Hayashi T, Sugibayashi K, Morimoto Y. (1992). Calculation of skin permeability coefficient for ionized and unionized species of Indomethacin. Chem pharm Bull 40:3090–3
   PubMed Web of Science ®Google Scholar
• Heuschkel S, Goebel A, Neubert RHH. (2008). Microemulsions—modern colloidal carrier for dermal and transdermal drug delivery. J Pharm Sci 97:603–31
   PubMed Web of Science ®Google Scholar
• Hua L, Weisan P, Jiayu L, Ying Z. (2004). Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. D Dev Ind Pharm 30:657–66
   PubMed Web of Science ®Google Scholar
• Ito T, Sugafuji T, Maruyama M, et al. (2001). Skin penetration by indomethacin is enhanced by use of an indomethacin/smectite complex. J Supramol Chem 1:217–9
   Google Scholar
• Jona JA, Dittert LW, Crooks PA, et al. (1995). Design of novel prodrugs for the enhancement of the transdermal penetration of indomethacin. Int J Pharm 123:127–30
   Web of Science ®Google Scholar
• Kanebako M, Inagi AT, Takayamab K. (2002). Transdermal delivery of indomethacin by iontophoresis. Biol Pharm Bull 25:779–82
   PubMed Web of Science ®Google Scholar
• Kathiresan K, Kiran K, Vijin P, et al. (2010). Formulation and development of indomethacin sustained release tablets. Int J PharmTech Res 2:794–7
   Google Scholar
• Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol 27:48–9
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35
   Web of Science ®Google Scholar
• Lawrencea MJ, Rees JD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121
   PubMed Web of Science ®Google Scholar
• Li T, Ren C, Wang M, et al. (2007). Optimized preparation and evaluation of indomethacin transdermal patch. Asian J Pharm Sci 2:249–59
   Google Scholar
• Miyazaki S. (1997). Effect of pulsed output ultrasound on the transdermal absorption of indomethacin from an ointment in rats. Biol Pharm Bull 20:288–91
   PubMed Web of Science ®Google Scholar
• Moreno MA, Ballesteros MP, Frutos P. (2003). Lecithin–based oil-in-water microemulsion for parenteral use: pseudoternary phase diagrams, characterization and toxicity studies. J Pharm Sci 92:1428–37
   PubMed Web of Science ®Google Scholar
• Ogiso T, Iwaki M, Paku T. (2006). Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J Pharm Sci 84:482–8
   Web of Science ®Google Scholar
• Rao PR, Diwan PV. (1998). Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. D Dev Ind Pharm 24:327–36
   PubMed Web of Science ®Google Scholar
• Sasaki H, Kojima M, Mori Y, et al. (1991). Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen. J Pharm Sci 80:533–8
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, et al. (2007). Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 66:227–43
   PubMed Web of Science ®Google Scholar
• Shakeel F, Baboota S, Ahuja A, et al. (2007). Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 8:E104
   PubMed Web of Science ®Google Scholar
• Shakeel F, Ramadan W. (2010). Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloids Surfaces B Biointerfaces 75:356–62
   PubMed Web of Science ®Google Scholar
• Shakeel F, Ramadan W, Ahmed MA. (2009). Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies. J Drug Targeting 17:435–41
   PubMed Web of Science ®Google Scholar
• Sharma PK, Bhatia SR. (2004). Effect of anti-inflammatories on pluronic F127: micellar assembly, gelation and partitioning. Int J Pharm 278:360--77
   Web of Science ®Google Scholar
• Stephen A, Mikulak C, Thomas V. (1998). Transdermal delivery and accumulation of indomethacin in subcutaneous tissues in rats. J Pharm Pharmacol 50:153–8
   PubMed Web of Science ®Google Scholar
• Strey R. (1994). Microemulsion microstructure and interfacial curvature. Colloid Polym Sci 272:1005–19
   Web of Science ®Google Scholar
• Taha E, Al-Suwayeh SA, El-Badry M. (2009). Bioavailability study of indomethacin self-nanoemulsifying oral formulation in rats. Australian J Basic Appl Sci 3:2944–8
   Google Scholar
• Trotta M. (1999). Influence of phase transformation on indomethacin release from microemulsions. J Cont Rel 60:399–405
   PubMed Web of Science ®Google Scholar
• Wang L, Dong J, Chen J, et al. (2009). Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 330:443–8
   PubMed Web of Science ®Google Scholar
• Wang RJ, Wu PC, Ang YBH, Tsai YH. (2008). The effects of iontophoresis and electroporation on transdermal delivery of meloxicam salts evaluated in vitro and in vivo. J Food Drug Anal 16:41–8
   Web of Science ®Google Scholar
• Zhang XG, Dong J-F, Zhang YG, et al. (2006). The effect of organic salts on the conductance of the water/AOT/alkanol w/o microemulsion. Acta Phys-Chim Sin 22:22–7
   Web of Science ®Google Scholar